再组合人体血小板蛋白作为一种新的血小板驱动调节剂,在急性肝衰竭中加速肝再生
Yunzhi Shen1,2, Fengzheng Han3,4, Tao Wang2,5
1Department of hepatobiliary surgery, Tianjin Third Central Hospital, Central Hospital, Tianjin University, Tianjin, China.
Frontiers in pharmacology
|January 28, 2026
概括
再组合人体血栓形成素 (rhTPO) 增强了急性肝衰竭 (ALF) 鼠的肝脏再生. 它可以增加血小板数量,刺激细胞增殖,减少炎症,促进肝功能恢复.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 再生医学是一种再生医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性肝衰竭 (ALF) 是一个严重的临床挑战,治疗选择有限.
- 肝脏再生是一个复杂的过程,对于从肝脏损伤中恢复至关重要.
- 血栓形成素 (TPO) 是血小板生产的关键调节剂,并且已被用于非血液形成功能.
研究的目的:
- 为了研究复合人体血栓形成素 (rhTPO) 在促进ALF的老鼠模型中的肝脏再生的治疗潜力.
- 阐明 rhTPO 影响肝脏修复过程的潜在分子机制.
主要方法:
- 在使用D-galactosamine (D-GalN) 的老鼠中诱导了一种ALF模型.
- 鼠被每天注射rhTPO或盐水 (对照组) 治疗.
- 评估了生存率,血小板计数,肝功能标志物 (ALT,TBil),肝细胞生长因子 (HGF),肝脏再生指数 (Ki67,BrdU),并进行了转录和蛋白质组分析.
主要成果:
- 与对照组相比,rhTPO治疗显著增加了血小板计数,血清TPO和HGF水平.
- 接受rhTPO治疗的动物表现出肝脏缩的减少,肝脏体重指数的改善,以及较低的ALT/TBil水平.
- rhTPO增强了肝脏的再生能力,由Ki67和BrdU指数的增加证明,以及与细胞增殖和炎症相关的调节基因表达.
结论:
- 在ALF大鼠中,rhTPO在促进肝功能恢复和增强肝脏再生方面表现出显著的治疗疗效.
- rhTPO的有益作用归因于血小板数量的增加,肝细胞增殖的刺激和炎症反应的抑制.
- rhTPO代表了一种有前途的治疗药物,用于治疗急性肝衰竭.
相关概念视频
01:24Liver Regeneration
4.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.3K
01:21Acute Respiratory Failure-I
977
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
977
01:21Acute Respiratory Failure-II
1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
01:29Acute Respiratory Failure-V
493
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
493
01:30Acute Respiratory Failure-III
869
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
869
01:23Acute Respiratory Failure-IV
555
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
555